Physician profile
Anne Le Tran
NPI 1639667884
$3,866.40
in general payments reported to CMS, 2019-2025
18 companies · $2,666 in 2025
The $2,666 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,200 · 2025: $2,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,866.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $656.96 | 2024-2025 | Otezla, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $491.04 | 2024-2025 | |
| Gilead Sciences, INC. | $467.46 | 2024-2025 | Vemlidy, Epclusa |
| Astrazeneca Pharmaceuticals LP | $445.06 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $407.83 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.28 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $248.53 | 2024-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $168.23 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Corcept Therapeutics | $149.88 | 2025 | Korlym |
| Axsome Therapeutics, INC. | $120.20 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $117.19 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $102.16 | 2025 | Capvaxive |
| Glaxosmithkline, LLC. | $87.85 | 2024-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Renalytix Ai, INC. | $62.38 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Organon LLC | $19.06 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.39 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $17.17 | 2025 | Thinprep 2000 Processor, Aptima |
| Medicomp INC | $13.73 | 2024 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.